Search Within

Katherine S Panageas

Formats
  1. Journal Article (316)
  2. Meeting Abstract (181)
  3. Editorial (5)
  4. Research Letter (5)
  5. Correspondence (4)
  6. Review (4)
  7. Book Section (3)
  8. Miscellaneous (1)
Groups
  1. Biostatistics Service (519)
  2. Epidemiology and Biostatistics (519)
  3. Population Sciences Research Program (519)
  4. Department of Medicine (305)
  5. Solid Tumor Oncology Division (263)
  6. GSK Faculty (188)

More Groups

People
  1. Anne Reiner (92)
  2. Jedd Wolchok (92)
  3. Lisa De Angelis (85)
  4. Paul Chapman (77)
  5. Michael Postow (66)
  6. Clifford Hudis (56)

More People

Years
  1. 2025 (15)
  2. 2024 (23)
  3. 2023 (28)
  4. 2022 (28)
  5. 2021 (34)
  6. 2020 (29)

More Years

Publications
  1. Journal of Clinical Oncology (109)
  2. Neuro-Oncology (40)
  3. Clinical Cancer Research (31)
  4. Annals of Surgical Oncology (28)
  5. Cancer (21)
  6. Breast Cancer Research and Treatment (20)

More Publications

Publishers
  1. American Society of Clinical Oncology (122)
  2. Oxford University Press (65)
  3. Springer (65)
  4. American Association for Cancer Research (56)
  5. Wiley Blackwell (38)
  6. American Medical Association (19)

More Publishers

Results (519)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Self-antigen-specifc CD8(+) T cell precursor frequency determines the quality of the antitumor immune response
    Journal Article

    Rizzuto, G. A.; Merghoub, T.; Hirschhorn-Cymerman, D.; Liu, C.; Lesokhin, A. M.; Sahawneh, D.; Zhong, H.; Panageas, K. S.; Perales, M. A.; Altan-Bonnet, G.; more...
    Journal of Experimental Medicine (2009)

    Fulltext@MSK | Save
  • Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: Molecular remissions predict for durable complete responses
    Journal Article

    Lamanna, N.; Jurcic, J. G.; Noy, A.; Maslak, P.; Gencarelli, A. N.; Panageas, K. S.; Heaney, M. L.; Brentjens, R. J.; Golde, D. W.; Scheinberg, D. A.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Prognosis and patterns of care in elderly patients with glioma
    Journal Article

    Iwamoto, F. M.; Reiner, A. S.; Nayak, L.; Panageas, K. S.; Elkin, E. B.; Abrey, L. E.
    Cancer (2009)

    Fulltext@MSK | Save
  • Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma
    Journal Article

    Clarke, J. L.; Iwamoto, F. M.; Sul, J.; Panageas, K.; Lassman, A. B.; DeAngelis, L.; Hormigo, A.; Nolan, C. P.; Gavrilovic, I.; Karimi, S.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase II trial of neoadjuvant temozolomide in advanced melanoma
    Meeting Abstract

    Shah, G. D.; Coit, D. G.; Brady, M.; Wolchok, J. D.; Carvajal, R. D.; Busam, K.; Panageas, K.; Roman, R.; Viale, A.; Socci, N.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • A longitudinal prospective study of YKL-40 and matrix metalloproteinase-9 (MMP-9) as serum tumor markers in gliomas
    Meeting Abstract

    Iwamoto, F. M.; Hottinger, A. F.; Karimi, S.; Riedel, E.; Panageas, K.; Gu, B.; Rao, J.; Fleisher, M.; Holland, E.; DeAngelis, L. M.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Pilot study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma
    Meeting Abstract

    Perales, M. A.; Yuan, J.; Powel, S.; Gallardo, H. F.; Rasalan, T. S.; Gonzalez, C.; Manukian, G.; Wang, J.; Zhang, Y.; Chapman, P. B.; more...
    Cancer Research (2008)

    Fulltext@MSK | Save
  • Association of increased number of sentinel lymph nodes with unfavorable pathologic features of primary melanoma
    Meeting Abstract

    Schmidt, C. R.; Panageas, K. S.; Coit, D.; Patel, A.; Brady, M. S.
    Annals of Surgical Oncology (2008)

    Fulltext@MSK | Save
  • Patterns of care in elderly patients with oligodendroglioma
    Meeting Abstract

    Nayak, L.; Iwamoto, F.; Reiner, A.; Panageas, K.; Elkin, E.; Abrey, L.
    Neuro-Oncology (2008)

    Fulltext@MSK | Save
  • Ykl-40 and matrix metalloproteinase-9 (Mmp-9) as serum tumor markers in gliomas
    Meeting Abstract

    Iwamoto, F.; Hottinger, A.; Jahdi, M.; Dantis, J.; Karimi, S.; Riedel, E.; Panageas, K.; Gu, B.; Rao, J.; Fleisher, M.; more...
    Neuro-Oncology (2008)

    Fulltext@MSK | Save